A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA
<p><strong>Background:</strong> Aspergillus infection is known to be associated with worse respiratory outcomes in people with CF (pwCF) and is a well-recognised complication of severe SARS-CoV-2 infection. The aim of this observational cross-sectional study was to examine the asso...
Main Authors: | Bradbury, JD, Chesshyre, E, Orenti, A, Jung, A, Warris, A, European Cystic Fibrosis COVID project group |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2023
|
Títulos similares
-
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
por: Moïse Michel, et al.
Publicado: (2022-06-01) -
The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience
por: Emily L. D. Chesshyre, et al.
Publicado: (2024-10-01) -
ABPA or AFAA: That is the question
por: Wardlaw, A, et al.
Publicado: (2011) -
Specific antibodies to recombinant allergens of <it>Aspergillus fumigatus </it>in cystic fibrosis patients with ABPA
por: Moss Richard B, et al.
Publicado: (2006-07-01) -
Allergic Bronchopulmonary Aspergillosis (ABPA) With Colonized Aspergillus fumigatus Detected by Metagenomic Next‐Generation Sequencing on Tissue Samples: A Distinct Subset of ABPA With a Higher Risk of Exacerbation
por: Wanjun Wang, et al.
Publicado: (2024-06-01)